Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
Authors:
Open Access
- 20 May 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Integrative Neuroscience
- Vol. 15
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a chronic and progressive disorder estimated to affect at least 4 million people worldwide. Although the etiology of PD remains unclear, it has been found that the dysfunction of synaptic vesicle endocytosis (SVE) in neural terminal happens before the loss of dopaminergic neurons. Recently, accumulating evidence reveals that the PD-linked synaptic genes, including DNAJC6, SYNJ1, and SH3GL2, significantly contribute to the disruptions of SVE, which is vital for the pathogenesis of PD. In addition, the proteins encoded by other PD-associated genes such as SNCA, LRRK2, PRKN, and DJ-1 also play key roles in the regulation of SVE. Here we present the facts about SVE-related genes and discussed their potential relevance to the pathogenesis of PD.Keywords
Funding Information
- National Natural Science Foundation of China (81822016, 81771382, 81571249)
This publication has 134 references indexed in Scilit:
- Progressive degeneration of human neural stem cells caused by pathogenic LRRK2Nature, 2012
- External push and internal pull forces recruit curvature-sensing N-BAR domain proteins to the plasma membraneNature Cell Biology, 2012
- Recruitment of Endophilin to Clathrin-Coated Pit Necks Is Required for Efficient Vesicle Uncoating after FissionNeuron, 2011
- DJ-1 associates with synaptic membranesNeurobiology of Disease, 2011
- Synaptojanin 1-Mediated PI(4,5)P2 Hydrolysis Is Modulated by Membrane Curvature and Facilitates Membrane FissionDevelopmental Cell, 2011
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementiaActa Neuropathologica, 2010
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic functionEMBO Molecular Medicine, 2009
- The Dual Phosphatase Activity of Synaptojanin1 Is Required for Both Efficient Synaptic Vesicle Endocytosis and Reavailability at Nerve TerminalsNeuron, 2007
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003